KITE PHARMA INC's ticker is and the CUSIP is 49803L959. A total of 3 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $9,764,000 | +19.1% | 543 | -31.4% | 0.64% | +19.0% |
Q2 2017 | $8,200,000 | +259.0% | 791 | +171.8% | 0.54% | +335.8% |
Q1 2017 | $2,284,000 | +75.0% | 291 | 0.0% | 0.12% | +61.8% |
Q4 2016 | $1,305,000 | -80.2% | 291 | -75.3% | 0.08% | -69.1% |
Q3 2016 | $6,575,000 | +32.1% | 1,177 | +45.7% | 0.25% | -10.2% |
Q4 2015 | $4,979,000 | -50.9% | 808 | -55.7% | 0.27% | -34.4% |
Q3 2015 | $10,150,000 | +1531.8% | 1,823 | +1687.3% | 0.42% | +1717.4% |
Q2 2015 | $622,000 | +10.1% | 102 | +4.1% | 0.02% | -4.2% |
Q1 2015 | $565,000 | – | 98 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 11,600 | $669,000 | 0.01% |
Citadel Advisors | 28,400 | $1,638,000 | 0.00% |
SIMPLEX TRADING, LLC | 99 | $10,000 | 0.00% |